{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-25-009661","form_type":"8-K","ticker":"PMI","cik":"0002030617","company_name":"Picard Medical, Inc.","filed_at":"2025-12-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.390804+00:00","generated_at":"2026-05-16T15:30:54.493138+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Picard Medical CEO to present Emperor TAH data at CSI Focus D-HF in Frankfurt","bullets":["CEO Patrick NJ Schnegelsberg presenting on December 6, 2025 at 13:00 CET in the 'Durable Mechanical Circulatory Support' session.","Emperor Total Artificial Heart (TAH) is a fully implantable device; Picard's subsidiary SynCardia makes the first FDA/Health Canada-approved total artificial heart.","Conference runs December 5-6, 2025 in Frankfurt, Germany; no new financial or operational guidance disclosed in the release."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-25-009661","json":"https://secwatch.observer/filing/0001829126-25-009661.json","markdown":"https://secwatch.observer/filing/0001829126-25-009661.md","text":"https://secwatch.observer/filing/0001829126-25-009661.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2030617/000182912625009661/0001829126-25-009661-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2030617/000182912625009661/picardmedical_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T15:30:54.493138+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}